General description
Chloramine T (CAT) trihydrate is a commonly used reagent for organic synthesis especially in heterocyclic chemistry. CAT is an active chlorine compound that shows antimicrobial activity.
Application
Chloramine T trihydrate may be used as an oxidizing agent in the synthesis of 8-chloro-[1,2,4]triazolo[4,3-a]pyrazine derivatives and novel isoxazolines.
It may also be used in the synthesis of the following compounds:
- Nitrile imines by the oxidative dehydrogenation of N-(nitrobenzyl)-imidazole aldehyde hydrazine.
- Mono-N-tosylated-1,2-diamines.
- 3,5-Disubstituted isoxazoles.
- Fused 3,6-disubstituted triazolothiadiazoles by the oxidative cyclization of N-heteroaryl-substituted hydrazones.
Nitrene source for aziridinations and aminohydroxylations.
Packaging
Capable of oxidative cyclization to produce various heterocycles.
Molecular Weight: 281.69. Empirical Formula: C7H7ClNNaO2S · 3H2O. linearFormula: CH3C6H4SO2NClNa · 3H2O. grade: ACS reagent. Quality Level: 200. Assay: 98%, 98.0-103.0% (ACS specification). form: powder. reaction suitability: reagent type: oxidant. impurities: <. 1.5% insolubles (alcohol). pH: 8.0-10.0 (25 . °C, 5%). mp: 167-170 . °C (lit.). solubility: H2O: passes test. suitability: passes test for determination of bromide. SMILES string: O.O.O.Cc1ccc(cc1)S(: O)(: O)N([Na])Cl. InChI: 1S/C7H7ClNO2S.Na.3H2O/c1-6-2-4-7(5-3-6)12(10,11)9-8. . . . /h2-5H,1H3. . 3*1H2/q-1. +1. . . . InChI key: NZYOAGBNMCVQIV-UHFFFAOYSA-N. Pictograms: GHS05,GHS07,GHS08. Signal Word: Danger. Hazard Statements: H302 - H314 - H334. Precautionary Statements: P260 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P310 - P305 + P351 + P338. Hazard Classifications: Acute Tox. 4 Oral - Eye Dam. 1 - Resp. Sens. 1 - Skin Corr. 1B. Supp Hazards: EUH031. Storage Class Code: 8A - Combustible, corrosive hazardous materials. WGK: WGK 2. Flash Point(F): 377.6 °F - closed cup. Flash Point(C): 192 °C - closed cup.- UPC:
- 12141901
- Condition:
- New
- HazmatClass:
- Yes
- MPN:
- 402869-100G
- CAS:
- 7080-50-4
akash.verma@cenmed.com
(732) 447-1115





